GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (BSP:R1MD34) » Definitions » Shiller PE Ratio

ResMed (BSP:R1MD34) Shiller PE Ratio : (As of Apr. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is ResMed Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


ResMed Shiller PE Ratio Historical Data

The historical data trend for ResMed's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed Shiller PE Ratio Chart

ResMed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.20 74.10 85.38 60.24 55.64

ResMed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.70 55.64 36.63 42.10 -

Competitive Comparison of ResMed's Shiller PE Ratio

For the Medical Instruments & Supplies subindustry, ResMed's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ResMed's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ResMed's Shiller PE Ratio falls into.



ResMed Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

ResMed's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, ResMed's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.54/129.4194*129.4194
=2.540

Current CPI (Mar. 2024) = 129.4194.

ResMed Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.341 100.560 0.439
201409 0.339 100.428 0.437
201412 0.423 99.070 0.553
201503 0.503 99.621 0.653
201506 0.475 100.684 0.611
201509 0.566 100.392 0.730
201512 0.660 99.792 0.856
201603 0.592 100.470 0.763
201606 0.505 101.688 0.643
201609 0.439 101.861 0.558
201612 0.453 101.863 0.576
201703 0.485 102.862 0.610
201706 0.585 103.349 0.733
201709 0.470 104.136 0.584
201712 0.058 104.011 0.072
201803 0.623 105.290 0.766
201806 0.716 106.317 0.872
201809 0.750 106.507 0.911
201812 0.835 105.998 1.020
201903 0.701 107.251 0.846
201906 0.463 108.070 0.554
201909 0.855 108.329 1.021
201912 1.129 108.420 1.348
202003 1.368 108.902 1.626
202006 1.582 108.767 1.882
202009 1.647 109.815 1.941
202012 1.582 109.897 1.863
202103 -0.761 111.754 -0.881
202106 1.672 114.631 1.888
202109 1.834 115.734 2.051
202112 1.937 117.630 2.131
202203 1.518 121.301 1.620
202206 1.678 125.017 1.737
202209 1.875 125.227 1.938
202212 2.006 125.222 2.073
202303 2.057 127.348 2.090
202306 1.893 128.729 1.903
202309 1.840 129.860 1.834
202312 1.739 129.419 1.739
202403 2.540 129.419 2.540

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ResMed  (BSP:R1MD34) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


ResMed Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of ResMed's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ResMed (BSP:R1MD34) Business Description

Address
9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

ResMed (BSP:R1MD34) Headlines

No Headlines